Global Biologic Therapeutics Market 2024-2028

Global Biologic Therapeutics Market 2024-2028

The biologic therapeutics market is forecasted to grow by USD 398.3 bn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of biosimilars, increasing incidence of chronic diseases and immunological disorders, and patent expiry of major biologics.

Technavio's biologic therapeutics market is segmented as below:

By Application

• Cancer
• Infectious diseases
• Autoimmune diseases
• Others

By Product

• Antibody therapeutics
• Vaccines
• Cell therapy
• Gene therapy
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong research and development pipeline as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, targeted therapeutic mechanism of biologics and increasing investment in developing biologics will lead to sizable demand in the market.

The report on the biologic therapeutics market covers the following areas:

• Biologic therapeutics market sizing
• Biologic therapeutics market forecast
• Biologic therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.